Ferroptosis in osteogenic differentiation: a narrative review of bone regeneration metabolism
Open Access
- 12 May 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Regenerative Medicine Reports
- Vol. 2 (3) , 100-107
Abstract
Bone healing is a complex multifactor and diverse physiological process. In terms of osteogenic differentiation, different types of regulated cell death, such as ferroptosis, play key roles in the bone microenvironment. Ferroptosis is a new type of regulated cell death discovered in 2012. It is characterized by lipid peroxidation and iron-dependent accumulation, which are closely related to various clinical challenges. In recent years, an increasing number of studies have indicated a strong potential relationship between ferroptosis and different orthopedic diseases, including osteoporosis, osteopenia and osteoarthritis. Hence, an in-depth investigation of the relationship between ferroptosis and bone metabolism is highly important for the treatment of orthopedic diseases. Moreover, ferroptosis is also accompanied by morphological changes in mitochondria, such as increased membrane density and shrunken mitochondria, which have been detected in osteoblasts, bone marrow stem mesenchymal cells and osteoclasts. The inhibition of ferroptosis can reduce mitochondrial damage, alleviate oxidative stress and promote bone regeneration. This article reviews the mechanism of ferroptosis from the aspects of iron overload and the regulation of ferroptosis-related pathways, as well as their effects on bone regeneration. Increasing evidence has shown that bone defect healing and bone regeneration processes are closely related to abnormal iron metabolism. Inhibiting ferroptosis in bone marrow mesenchymal stem cells or osteoblasts can effectively improve the bone healing rate and promote bone regeneration progression. We discuss the detailed mechanism of ferroptosis and summarize the current research on ferroptosis and bone disease treatment.Keywords
This publication has 112 references indexed in Scilit:
- Identification of NIBAN2‐Regulated RUNX2 Alternative Splicing Presents Novel Strategies for Antagonizing OsteoporosisAdvanced Science, 2025
- Naringenin Inhibits Ferroptosis in Renal Tubular Epithelial Cells of Diabetic Nephropathy Through SIRT1/FOXO3a Signaling PathwayDrug Development Research, 2025
- Ferroptosis in Osteocytes as a Target for Protection Against Postmenopausal OsteoporosisAdvanced Science, 2024
- Protective effect of rutin on ferroptosis‐induced oxidative stress in aging laying hens through Nrf2/HO‐1 signalingCell Biology International, 2022
- Iron overload‐induced ferroptosis of osteoblasts inhibits osteogenesis and promotes osteoporosis: An in vitro and in vivo studyIUBMB Life, 2022
- IFNγ-mediated repression of system xc− drives vulnerability to induced ferroptosis in hepatocellular carcinoma cellsJournal of Leukocyte Biology, 2021
- Exosomes derived from vascular endothelial cells antagonize glucocorticoid‐induced osteoporosis by inhibiting ferritinophagy with resultant limited ferroptosis of osteoblastsJournal of Cellular Physiology, 2021
- Protective Effects of Antioxidant Polyphenols against Hyperglycemia‐Mediated Alterations in Cerebral Endothelial Cells and a Mouse Stroke ModelMolecular Nutrition & Food Research, 2020
- GPX4 at the Crossroads of Lipid Homeostasis and FerroptosisProteomics, 2019
- Salidroside promotes rat spinal cord injury recovery by inhibiting inflammatory cytokine expression and NF‐κB and MAPK signaling pathwaysJournal of Cellular Physiology, 2019